IRIS
MORBELLI, SILVIA DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.655
Totale 23.655
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.655
Totale 23.655
Salva come PNG Salva come JPEG
Città #
Genova 15.538
Rapallo 3.211
Genoa 2.974
Vado Ligure 1.834
Bordighera 98
Totale 23.655
Salva come PNG Salva come JPEG
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 303
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 171
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity 169
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. 159
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 156
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 148
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 146
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 146
Amyloid positron emission tomography and cognitive reserve. 145
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 144
Intrabone Transplant of Cord Blood Stem Cells Establishes a Local Engraftment Store: A Functional PET/FDG Study 140
A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View. 139
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 139
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. 138
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 137
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 136
Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. 133
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 133
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 131
Adult Advanced Chronic Lymphocytic Leukemia: Computational Analysis of Whole-Body CT Documents a Bone Structure Alteration 130
Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events? 130
Neuroimaging findings in mild cognitive impairment 130
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 129
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 129
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 129
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 127
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 127
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 125
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 125
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 123
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 123
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 123
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. 122
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 122
Assessment of skeletal tumor load in metastasized castration-resistant prostate cancer patients: A review of available methods and an overview on future perspectives 122
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 122
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 121
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 121
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis 120
What predicts cognitive decline in de novo Parkinson's disease? 119
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 118
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 117
A new frontier for amyloid PET imaging: multiple sclerosis 117
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 116
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 116
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 116
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 115
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 115
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 114
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 114
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 114
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 114
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 113
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 113
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 112
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 112
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 112
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 112
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 110
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 110
The role of the serotonergic system in REM sleep behavior disorder 110
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells 110
Trafficking and homing of systemically administered stem cells: the need for appropriate analysis tools of radionuclide images 109
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 109
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. 109
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 108
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting 107
Early identification of MCI converting to AD: a FDG PET study 106
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 106
Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome 105
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 105
Brain glucose metabolism and cognitive function in patients with amnestic Mild Cognitive Impairment (MCI) 104
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. 104
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 104
Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress 104
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 103
Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions 103
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 103
New tracers and new perspectives for molecular imaging in Lewy body diseases 103
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 102
Functional imaging in pre-motor Parkinson's disease 101
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 101
Obligatory role of endoplasmic reticulum in brain FDG uptake 101
Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. 100
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. 100
FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study 100
Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis 100
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 99
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 99
The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging 98
Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging 97
Differentiated thyroid cancer incidentally detected by 18F-FDG PET/CT: Patient's future in a hot-spot? 97
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 97
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia 96
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 96
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence 96
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 95
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: Results from the ENC-DAT database 95
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 95
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 95
Totale 11.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.604
article - articoli 81.166
book - libri 0
conference - conferenze 8.171
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.267
Totale 183.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.995 0 0 0 0 488 649 818 475 665 1.059 669 172
2020/20212.403 139 209 178 221 141 251 200 222 193 263 184 202
2021/20223.300 82 114 231 381 151 278 136 679 265 355 143 485
2022/20233.748 303 331 63 377 549 564 35 334 598 89 459 46
2023/20242.462 118 262 46 321 196 471 162 165 108 76 125 412
2024/20252.045 283 511 228 533 490 0 0 0 0 0 0 0
Totale 24.395